Login
ZELIRA THERAPEUTICS LTD
ZELIRA THERAPEUTICS
Updated on 26 Nov 2021 (End of trading day)
| Last (AUD): 0.036 | Change: - | High: 0.037 | Remarks: - |
| Change (%): - | Low: 0.036 |
Loading search items...
Mode - Streaming
Switch to Static Mode?
Price Highlight
Index Highlight
STI
3,166.3
-55.2 (-1.72%)
-
STI Straits Times Index
3,166.3-55.2 (-1.72%) -
KLCI FTSE Bursa Malaysia KLCI
1,512.2-5.4 (-0.35%)Index delayed 15 minutes -
HSI Hang Seng Index
24,080.5-659.6 (-2.67%)Index delayed 15 minutes -
SSE SSE Composite Index
3,564.1-20.1 (-0.56%)Index delayed 15 minutes -
N225 Nikkei 225
28,751.6-747.7 (-2.53%)Index delayed 20 minutes -
JCI Jakarta Composite Index
6,561.6-137.8 (-2.06%)Index delayed 10 minutes
- Volume: 1,737.0M
- Value: 1,744.7M
- Rise: 72
- Fall: 305
- Unch: 381
Intraday Market Ticker Help
| Time | Name | Type | Price | Vol |
|---|
-
Top Active
-
Top Gainer
-
Top Loser
| Name | Last | Change |
|---|---|---|
| 0.021 | -0.004 | |
| 0.084 | -0.001 | |
| 0.400 | +0.110 | |
| 0.795 | -0.035 | |
| 0.695 | -0.020 | |
| 0.006 | -0.002 | |
| 2.440 | -0.030 | |
| 0.022 | +0.001 | |
| 1.550 | -0.020 | |
| 0.061 | - |
World Indices
| Name | Last | Change |
|---|---|---|
| Nasdaq | 15,491.7 | -353.6 |
| HSI | 24,080.5 | -659.6 |
| HSCEI | 8,576.1 | -233.7 |
| Jakarta | 6,561.6 | -137.8 |
| Nikkei 225 | 28,751.6 | -747.7 |
| SSE Comp | 3,564.1 | -20.1 |
| Shanghai A | 3,735.3 | -21.1 |
| Shanghai B | 281.0 | -1.2 |
| KOSPI | 2,936.4 | -43.8 |
Asian Indices delayed. US Indices updated twice daily at 7:30am and 7:30pm.
Fundamental - Factsheet
Help-
Factsheet
Free TrialCompany Background
Zelira Therapeutics Ltd. is a bio-pharmaceutical company. The firm engages in the research and development of cannabinoid-based formulations for the treatment of a variety of medical conditions. It focuses on human clinical trial program and pre-clinical research program. The company was founded by Harry Karelis, Mara Gordon, Jason Peterson, and Stewart Washer on February 18, 2003 and is headquartered in Perth, Australia.
Key Statistics
| EPS (AUD) a | -0.00670 | Trailing EPS (AUD) b | -0.00670 | NAV (AUD) c | 0.0296 |
|---|---|---|---|---|---|
| PE a | - | Trailing PE d | - | Price / NAV c | 1.2162 |
| Dividend Yield (%) e | - | Cash In Hand (AUD) f | 0.0039 | Issued & Paid-up Shares g | 1,276,230,000 |
| Piotroski F Score | 2 | Market Cap (M) | 45.944 | Free Float (%) | 74.1 |
| Return on Equity (ROE) (%) h | n.m. | Revenue Growth (%) TTM i | n.m. | ||
| Net Earnings Growth (%) j | -21.868 | Net Debt/Equity k | Net Cash | ||
| Sector & Industry | Process Industries - Agricultural Commodities/Milling | ||||
Notes:
-
Based on latest Full Year results announcement, adjusted based on Profit Attributable To Shareholders.
-
Summation of the earnings from the latest 4 Quarter (or 2 Half Year) results announcement, adjusted for the current number of shares.
-
Based on latest results announcement (Full Year, Half Year or Interim), adjusted for carrying value of "Other Share Capital", illustrative financial effects of corporate actions (if applicable) and the current number of shares.
-
Based on latest Full Year results announcement, adjusted for the current number of shares.
-
Dividend is based on latest Full Year results announcement, adjusted for current number of shares and excludes special dividend.
-
Based on reported cash and cash equivalents at end and extracted from the latest results announcement (Full Year, Half Year or Interim), adjusted for the current number of shares.
-
Rounded to the nearest thousand. The figure pertains to the respective exchange the stock is listed on. Updated on 08 Nov 2021. Please click here for more information.
-
Calculated based on Net Earnings / (Shareholders' Equity - Other Share Capital)
-
Calculated based on (Current Year Revenue - Last Year Revenue) / Last Year Revenue
-
Calculated based on (Current Year Earnings - Last Year Earnings) / Last Year Earnings
-
Calculated based on (Long Term Debt + Short Term Debt - Cash and Short Term Investments)/(Shareholders' Equity - Other Share Capital)
Total Shareholder Return
| Period | Dividend Received | Capital Appreciation | Total Shareholder Return | |||
|---|---|---|---|---|---|---|
| Short Term Return | 5 Days | - | -0.002 | -5.26 % | ||
| 10 Days | - | -0.006 | -14.29 % | |||
| 20 Days | - | -0.001 | -2.70 % | |||
| Medium Term Return | 3 Months | - | -0.002 | -5.26 % | ||
| 6 Months | - | -0.010 | -21.74 % | |||
| 1 Year | - | -0.041 | -53.25 % | |||
| Long Term Return | 2 Years | - | -0.031 | -46.27 % | ||
| 3 Years | - | -0.014 | -28.00 % | |||
| 5 Years | - | +0.005 | +16.13 % | |||
| Annualised Return | Annualised | - | - | +3.04 % | ||
Notes:
-
Total Shareholder Return (TSR) combines share price appreciation and dividends paid to show the total return to the shareholder expressed as a percentage.
-
Script dividends are ignored in this calculation.
Peer Comparison
Notes:
-
For companies, Market Cap is based on the trading currency of the company. Industry/Index Market Cap is the average market cap for that industry/index.
-
Industry/Index PE is calculated using (Total Market Cap/Total Earnings) of all companies in the industry/index.
-
Industry/Index Price/NAV is calculated using (Total Market Cap/Total Shareholders' Equity) of all companies in the industry/index.
-
Industry/Index Dividend Yield is calculated using (Total Gross Dividend/Total Market Cap) of all companies in the industry/index.
-
For Industry/Index calculation, data for foreign currency denominated companies will be converted to the main market currency using the latest exchange rate.
-
Industry/Index/Peers data is updated daily.
-
Peers are sorted by market capitalisation and only details for the top 10 will be shown.
More Information Available
More information is available to our subscribers, including:
- Consensus Estimates
- Comprehensive Financial Ratios(ROA, ROE, Price/Revenue, Net Earnings Margin, Current Ratio, Debt to Equity Ratio etc)
- Insider Buying and Selling Report
If you are an existing subscriber, please login. If not, read up on what you are missing out in our Help Centre and join us as a subscriber.
Disclaimer:
While reasonable efforts have been taken to ensure that the calculations performed by the features of this site are reliable, the features are provided on the basis that:-
- no liability is accepted for any errors or inaccuracies resulting from your use of these features;
- many of the data inputs (including share prices) are obtained from third party sources for which we assume no responsibility.